Lead-like, drug-like or “Pub-like”: how different are they?
暂无分享,去创建一个
Dan C. Fara | Tudor I. Oprea | Cristian Bologa | Tharun Kumar Allu | Ramona F. Rad | Lili Ostopovici | Liliana Ostopovici | Ramona F. Rad | D. Fara | T. Allu | C. Bologa
[1] Lawrence X. Yu,et al. A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan. , 2006, Molecular pharmaceutics.
[2] Jürgen Drews,et al. Innovation deficit revisited: reflections on the productivity of pharmaceutical R&D , 1998 .
[3] Tudor I. Oprea,et al. Rapid Evaluation of Synthetic and Molecular Complexity for in Silico Chemistry , 2005, J. Chem. Inf. Model..
[4] F. Lombardo,et al. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings , 1997 .
[5] Tudor I. Oprea,et al. Is There a Difference between Leads and Drugs? A Historical Perspective , 2001, J. Chem. Inf. Comput. Sci..
[6] T. Insel,et al. NIH Molecular Libraries Initiative , 2004, Science.
[7] Igor V. Tetko,et al. Prediction of n-Octanol/Water Partition Coefficients from PHYSPROP Database Using Artificial Neural Networks and E-State Indices , 2001, J. Chem. Inf. Comput. Sci..
[8] Tudor I. Oprea,et al. WOMBAT: World of Molecular Bioactivity , 2005 .
[9] Neera Jain,et al. Prediction of Aqueous Solubility of Organic Compounds by the General Solubility Equation (GSE) , 2001, J. Chem. Inf. Comput. Sci..
[10] Tudor I. Oprea. Current trends in lead discovery: Are we looking for the appropriate properties? , 2002, J. Comput. Aided Mol. Des..
[11] Andrew R. Leach,et al. Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery , 2001, J. Chem. Inf. Comput. Sci..
[12] Tudor I. Oprea,et al. Property distribution of drug-related chemical databases* , 2000, J. Comput. Aided Mol. Des..
[13] Andrew M. Davis,et al. Design kombinatorischer Leitstruktur‐Bibliotheken , 1999 .
[14] G. Poda,et al. Application of ALOGPS 2.1 to predict log D distribution coefficient for Pfizer proprietary compounds. , 2004, Journal of medicinal chemistry.
[15] Martyn G. Ford,et al. Simultaneous prediction of aqueous solubility and octanol/water partition coefficient based on descriptors derived from molecular structure , 2001, J. Comput. Aided Mol. Des..
[16] P. Leeson,et al. A comparison of physiochemical property profiles of development and marketed oral drugs. , 2003, Journal of medicinal chemistry.
[17] T I Oprea,et al. Cheminformatics: a tool for decision-makers in drug discovery. , 2001, Current opinion in drug discovery & development.
[18] J. Proudfoot. Drugs, leads, and drug-likeness: an analysis of some recently launched drugs. , 2002, Bioorganic & medicinal chemistry letters.
[19] A. Leo. CALCULATING LOG POCT FROM STRUCTURES , 1993 .
[20] I. Tetko,et al. Application of ALOGPS to predict 1-octanol/water distribution coefficients, logP, and logD, of AstraZeneca in-house database. , 2004, Journal of pharmaceutical sciences.
[21] Igor V. Tetko,et al. Virtual Computational Chemistry Laboratory – Design and Description , 2005, J. Comput. Aided Mol. Des..
[22] D. Lipman,et al. National Center for Biotechnology Information , 2019, Springer Reference Medizin.
[23] D F Horrobin,et al. Innovation in the pharmaceutical industry , 2000, Journal of the Royal Society of Medicine.